-
MPS Share Price Surges 13.77 Percent for Second Consecutive Session
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
No Comments
MPS share price rallies 13.77 percent for a second consecutive session, now 81.72 percent above its 52 week low. Check CMP, volume and key levels here.
-
Honasa Consumer vs Marico Business Model: Which Personal Care FMCG Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Honasa Consumer vs Marico business model compares direct-to-consumer beauty brand portfolio built around Mamaearth against hair care and edible oil brand-led portfolio to see which personal care fmcg has better business model.
-
Sai Life Sciences vs Divi’s Laboratories Business Model: Which Pharma CDMO Wins
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
Sai Life Sciences vs Divi’s Laboratories business model compares concentrated CDMO services for global innovator pharmaceutical companies against large-scale API and custom synthesis manufacturing for global pharmaceutical clients to see which pharma cdmo has better business model.
-
Honasa Consumer vs Nykaa Business Model: Which Beauty and Personal Care Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Honasa Consumer vs Nykaa business model compares direct-to-consumer beauty brand portfolio built around Mamaearth against inventory-led e-commerce marketplace with growing owned-brand contribution to see which beauty and personal care has better business model.
-
Oil Prices Today Edge Higher as US Strikes Iran for 11th Consecutive Night, Kuwait Reports Drone Attacks
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Oil prices today inched higher after the US struck Iranian military targets for an 11th straight night and Kuwait reported Iranian drone attacks. Brent and WTI levels here.
-
Sai Life Sciences vs Piramal Pharma Business Model: Which Pharma CDMO Wins
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
Sai Life Sciences vs Piramal Pharma business model compares concentrated CDMO services for global innovator pharmaceutical companies against diversified CDMO, complex hospital generics and consumer healthcare to see which pharma cdmo has better business model.
-
Suven Pharmaceuticals (Cohance) vs Sai Life Sciences Business Model: Which Pharma CDMO Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
Suven Pharmaceuticals (Cohance) vs Sai Life Sciences business model compares concentrated specialty pharma intermediate and CDMO manufacturing against concentrated CDMO services for global innovator pharmaceutical companies to see which pharma cdmo has better business model.
-
360 ONE Multi Asset Allocation Regular Growth: NAV Today, Performance Review and Should You Invest?
- July 22, 2026
- Posted by: Neeraj Pandey
- Category: News
360 ONE Multi Asset Allocation Regular Growth NAV, latest returns and full review including risks and how to invest.
-
DCM Shriram vs Chambal Fertilisers Business Model: Which Agri-Chemicals and Fertiliser Wins
- July 22, 2026
- Posted by: Ankit Jaiswal
- Category: News
DCM Shriram vs Chambal Fertilisers business model compares diversified conglomerate spanning sugar, chlor-alkali chemicals and fertiliser against concentrated fertiliser manufacturing and agri-input distribution to see which agri-chemicals and fertiliser has better business model.
-
GIC Re vs Medi Assist Healthcare Services Business Model: Which Insurance Ecosystem Wins
- July 22, 2026
- Posted by: Kunal Singla
- Category: News
GIC Re vs Medi Assist Healthcare Services business model compares PSU reinsurance underwriting risk transferred from primary insurers against third-party claims administration and processing services for insurers to see which insurance ecosystem has better business model.